{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:09:07Z","timestamp":1759482547613},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/ajkd.2002.36321","type":"journal-article","created":{"date-parts":[[2002,10,29]],"date-time":"2002-10-29T21:06:25Z","timestamp":1035925585000},"page":"916-923","source":"Crossref","is-referenced-by-count":17,"title":["Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment"],"prefix":"10.1053","volume":"40","author":[{"given":"Darren S.","family":"Parsons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Reaveley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell V.","family":"Pavitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwina A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2002.36321_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/ndt\/9.8.1136","article-title":"Comparative mortality from cardiovascular disease in patients with chronic renal failure","volume":"9","author":"Brown","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36321_bib2","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36321_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/ajkd.2001.26850","article-title":"Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment","volume":"38","author":"Landray","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36321_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2002.36321_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2362.1994.tb02373.x","article-title":"Lipoprotein(a) as a predictor for myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS)","volume":"24","author":"Cremer","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/ajkd.2002.36321_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.20.2.493","article-title":"Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women","volume":"20","author":"Foody","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/ajkd.2002.36321_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archinte.1994.00420070129015","article-title":"Lp(a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men","volume":"154","author":"Valentine","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2002.36321_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.37.3.513","article-title":"Lipoprotein(a) in ischaemic cerebrovascular disease: A new approach to the assessment of stroke","volume":"37","author":"Jurgens","year":"1987","journal-title":"Neurology"},{"key":"10.1053\/ajkd.2002.36321_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0021-9150(86)90099-7","article-title":"The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels","volume":"62","author":"Armstrong","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multi-centre study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by haemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in haemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36321_bib12","first-page":"271","article-title":"High serum lipoprotein(a) concentrations in uraemic patients treated with continuous ambulatory peritoneal dialysis","volume":"38","author":"Shoji","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib13","first-page":"354","article-title":"Lipids and lipoprotein(a) as risk factors for vascular disease in patients on renal replacement therapy","volume":"10","author":"Webb","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36321_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.86.2.475","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in haemodialysis patients","volume":"8","author":"Cressman","year":"1992","journal-title":"Circulation"},{"issue":"suppl 71","key":"10.1053\/ajkd.2002.36321_bib15","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1046\/j.1523-1755.1999.07167.x","article-title":"Lipoprotein(a) is a predictor for cardiovascular mortality of haemodialysis patients","volume":"56","author":"Koda","year":"1999","journal-title":"Kidney Int"},{"issue":"suppl 71","key":"10.1053\/ajkd.2002.36321_bib16","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1046\/j.1523-1755.1999.07164.x","article-title":"Lipoprotein(a) as a risk factor for coronary artery disease in haemodialysis patients","volume":"56","author":"Ohashi","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36321_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.V1051027","article-title":"The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in haemodialysis patients: A prospective follow-up","volume":"10","author":"Kronenberg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.V8121889","article-title":"Apolipoprotein B, fibrinogen, HDL cholesterol and apolipoprotein(a) phenotypes predict coronary artery disease in haemodialysis patients","volume":"8","author":"Kock","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7326\/0003-4819-129-6-199809150-00006","article-title":"Increased serum lipoprotein(a) levels in patients with early renal disease","volume":"129","author":"Sechi","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36321_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1159\/000188970","article-title":"Serum lipoprotein(a) concentration is increased in moderate renal failure","volume":"72","author":"Arnadottir","year":"1996","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2002.36321_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.V111105","article-title":"Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure","volume":"11","author":"Kronenberg","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.V61121","article-title":"Hyper-homocysteinaemia and the risk for vascular disease in haemodialysis patients","volume":"6","author":"Bachmann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib23","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyper-homocysteinaemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.36321_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(96)05865-0","article-title":"Hyperhomocysteinemia, hyperfibrinogenemia and lipoprotein(a) excess in maintenance dialysis patients: A matched case-control study","volume":"125","author":"Bostom","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1053\/ajkd.2002.36321_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36321_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","article-title":"Serum total homocysteine and coronary heart disease","volume":"24","author":"Arnesen","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1053\/ajkd.2002.36321_bib28","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/ajkd.2002.36321_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","article-title":"Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease","volume":"97","author":"Moustapha","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.36321_bib30","first-page":"230","article-title":"Plasma homocysteine in renal failure","volume":"40","author":"Hultberg","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365519609088586","article-title":"The effect of reduced glomerular filtration rate on plasma total homocysteine concentration","volume":"56","author":"Arnadottir","year":"1996","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1053\/ajkd.2002.36321_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-9150(01)00502-0","article-title":"Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: Critical impact of true glomerular filtration rate","volume":"159","author":"Bostom","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36321_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(81)90103-9","article-title":"Lipoprotein(a) and the risk of myocardial infarction","volume":"38","author":"Kostner","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2796.1997.00239.x","article-title":"Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study","volume":"242","author":"Bots","year":"1997","journal-title":"J Intern Med"},{"key":"10.1053\/ajkd.2002.36321_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.ATV.10.2.240","article-title":"Lipoprotein(a), fibrin binding and plasminogen binding","volume":"10","author":"Loscalzo","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib37","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.89.21.10193","article-title":"Homocysteine and other sulfhydral compounds enhance the binding of lipoprotein(a) to fibrin: A potential link between thrombosis, atherogenesis, and sulfhydal compound metabolism","volume":"89","author":"Harpel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/ajkd.2002.36321_bib38","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.95.7.1777","article-title":"Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and the risk of future venous thromboembolism","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.36321_bib39","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","article-title":"Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans","volume":"37","author":"Marcovina","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1053\/ajkd.2002.36321_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-2423(08)60426-6","article-title":"Lipoprotein(a)","volume":"32","author":"van den Ende","year":"1996","journal-title":"Adv Clin Chem"},{"key":"10.1053\/ajkd.2002.36321_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365597809179980","article-title":"Determination of glomerular filtration rate in advanced renal insufficiency","volume":"12","author":"Jagenburg","year":"1978","journal-title":"Scand J Urol Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinchem\/39.2.263","article-title":"Homocysteine and other thiols in plasma and urine","volume":"39","author":"Fiskerstrand","year":"1993","journal-title":"Clin Chem"},{"key":"10.1053\/ajkd.2002.36321_bib43","first-page":"609","article-title":"Lipoprotein(a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis","volume":"8","author":"Webb","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36321_bib44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI117126","article-title":"Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles","volume":"93","author":"Perombelon","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2002.36321_bib45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0272-6386(99)70147-2","article-title":"Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure","volume":"33","author":"Milinois","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36321_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116213","article-title":"Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)","volume":"91","author":"Dieplinger","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2002.36321_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2796.1994.tb00856.x","article-title":"Homocysteine and cysteine\u2014Determinants of plasma levels in middle-aged and elderly subjects","volume":"236","author":"Brattstrom","year":"1995","journal-title":"J Intern Med"},{"key":"10.1053\/ajkd.2002.36321_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(95)05522-X","article-title":"Net uptake of plasma homocysteine by rat kidney uptake in vivo","volume":"116","author":"Bostom","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2002.36321_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1523-1755.1998.00983.x","article-title":"No net renal extraction of homocysteine in fasting humans","volume":"54","author":"van Guldener","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36321_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-119-4-199308150-00002","article-title":"Elevated plasma lipoprotein(a) in nephrotic syndrome","volume":"119","author":"Wanner","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36321_bib51","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.V981474","article-title":"Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome","volume":"9","author":"de Sain-van der Velden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36321_bib52","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0022-2275(20)37150-9","article-title":"Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation","volume":"38","author":"Kronenberg","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1053\/ajkd.2002.36321_bib53","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI118487","article-title":"Apolipoprotein(a) kringle 4-containing fragments in urine: Relationship to plasma levels of lipoprotein(a)","volume":"97","author":"Mooser","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2002.36321_bib54","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/clinchem\/38.11.2244","article-title":"Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure","volume":"38","author":"Oida","year":"1992","journal-title":"Clin Chem"},{"key":"10.1053\/ajkd.2002.36321_bib55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","article-title":"Homocysteine and coronary atherosclerosis","volume":"27","author":"Mayer","year":"1996","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602500299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602500299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T01:08:44Z","timestamp":1622336924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602500299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0272638602500299"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2002.36321","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}